Use of galiella lactone

US6512007B1 · kind B1 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Jorg Baumgarten · Wuppertal, DE
• Marcus Weidler · Odenthal, DE
• Gerhard Erkel · Kaiserslautern, DE
• Heidrun Anke · Kaiserslautern, DE
• Timm Anke · Kaiserslautern, DE

Key dates

• Filing date: Jun 29, 2001
• Grant date: Jan 28, 2003
• Expiry date: Jun 29, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of the substance known under the name of galiella lactone as pharmaceutical, in particular for the treatment of inflammatory processes.